Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Tao Zuo, Fen Zhang, Grace C Y Lui, Yun Kit Yeoh, Amy Y L Li, Hui Zhan, Yating Wan, Arthur C K Chung, Chun Pan Cheung, Nan Chen, Christopher K C Lai, Zigui Chen, Eugene Y K Tso, Kitty S C Fung, Veronica Chan, Lowell Ling, Gavin Joynt, David S C Hui, Francis K L Chan, Paul K S Chan, Siew C Ng, Tao Zuo, Fen Zhang, Grace C Y Lui, Yun Kit Yeoh, Amy Y L Li, Hui Zhan, Yating Wan, Arthur C K Chung, Chun Pan Cheung, Nan Chen, Christopher K C Lai, Zigui Chen, Eugene Y K Tso, Kitty S C Fung, Veronica Chan, Lowell Ling, Gavin Joynt, David S C Hui, Francis K L Chan, Paul K S Chan, Siew C Ng
Abstract
Background & aims: Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects gastrointestinal tissues, little is known about the roles of gut commensal microbes in susceptibility to and severity of infection. We investigated changes in fecal microbiomes of patients with SARS-CoV-2 infection during hospitalization and associations with severity and fecal shedding of virus.
Methods: We performed shotgun metagenomic sequencing analyses of fecal samples from 15 patients with Coronavirus Disease 2019 (COVID-19) in Hong Kong, from February 5 through March 17, 2020. Fecal samples were collected 2 or 3 times per week from time of hospitalization until discharge; disease was categorized as mild (no radiographic evidence of pneumonia), moderate (pneumonia was present), severe (respiratory rate ≥30/min, or oxygen saturation ≤93% when breathing ambient air), or critical (respiratory failure requiring mechanical ventilation, shock, or organ failure requiring intensive care). We compared microbiome data with those from 6 subjects with community-acquired pneumonia and 15 healthy individuals (controls). We assessed gut microbiome profiles in association with disease severity and changes in fecal shedding of SARS-CoV-2.
Results: Patients with COVID-19 had significant alterations in fecal microbiomes compared with controls, characterized by enrichment of opportunistic pathogens and depletion of beneficial commensals, at time of hospitalization and at all timepoints during hospitalization. Depleted symbionts and gut dysbiosis persisted even after clearance of SARS-CoV-2 (determined from throat swabs) and resolution of respiratory symptoms. The baseline abundance of Coprobacillus, Clostridium ramosum, and Clostridium hathewayi correlated with COVID-19 severity; there was an inverse correlation between abundance of Faecalibacterium prausnitzii (an anti-inflammatory bacterium) and disease severity. Over the course of hospitalization, Bacteroides dorei, Bacteroides thetaiotaomicron, Bacteroides massiliensis, and Bacteroides ovatus, which downregulate expression of angiotensin-converting enzyme 2 (ACE2) in murine gut, correlated inversely with SARS-CoV-2 load in fecal samples from patients.
Conclusions: In a pilot study of 15 patients with COVID-19, we found persistent alterations in the fecal microbiome during the time of hospitalization, compared with controls. Fecal microbiota alterations were associated with fecal levels of SARS-CoV-2 and COVID-19 severity. Strategies to alter the intestinal microbiota might reduce disease severity.
Keywords: Bacteria; Coronavirus; Fecal Nucleic Acid; Gut Microbiome.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
- Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy [published online ahead of print March 23, 2020]. JAMA .
- Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
- Chen N., Zhou M., Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
- Liang W., Feng Z., Rao S. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. 2020;69:1141–1143.
- Cheung K.S., Hung I.F.N., Chan P.P.Y. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterology. 2020;159:81–95.
- Wölfel R., Corman V.M., Guggemos W. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469.
- Xu Y., Li X., Zhu B. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nature Medicine. 2020;26:502–505.
- Effenberger M., Grabherr F., Mayr L. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020;69:1543–1544.
- Shang J., Ye G., Shi K. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221–224.
- Wang J, Zhao S, Liu M, et al. ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism [published online ahead of print February 5, 2020]. medRxiv doi: 10.1101/2020.02.05.20020545.
- Xiao F., Tang M., Zheng X. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158:1831–1833.e3.
- Hashimoto T., Perlot T., Rehman A. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487:477–481.
- Ma W.-T., Pang M., Fan Q.-L. The commensal microbiota and viral infection: a comprehensive review. Front Immunol. 2019;10:1551.
- Hanada S., Pirzadeh M., Carver K.Y. Respiratory viral infection-induced Microbiome alterations and secondary bacterial pneumonia. Front Immunol. 2018;9:2640.
- Yildiz S., Mazel-Sanchez B., Kandasamy M. Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis. Microbiome. 2018;6:9.
- Shen Z., Xiao Y., Kang L. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients. Clin Infect Dis. 2020;71:713–720.
- Turnbaugh P.J., Ley R.E., Mahowald M.A. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027.
- Emoto T., Yamashita T., Sasaki N. Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease. Journal of atherosclerosis and thrombosis. 2016;23:908–921.
- Yang T., Santisteban M.M., Rodriguez V. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65:1331–1340.
- Ley R.E., Turnbaugh P.J., Klein S. Human gut microbes associated with obesity. nature. 2006;444:1022–1023.
- Geva-Zatorsky N., Sefik E., Kua L. Mining the human gut microbiota for immunomodulatory organisms. Cell. 2017;168:928–943.e11.
- Kalantar-Zadeh K., Ward S.A., Kalantar-Zadeh K. Considering the effects of microbiome and diet on SARS-CoV-2 infection: nanotechnology roles. ACS Nano. 2020;14:5179–5182.
- Wu J., Liu J., Zhao X. Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis. 2020;71:706–712.
- Bolger A.M., Lohse M., Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–2120.
- Segata N., Waldron L., Ballarini A. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods. 2012;9:811.
- Morgan X.C., Tickle T.L., Sokol H. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.
- Elsayed S., Zhang K. Human infection caused by Clostridium hathewayi. Emerg Infect Dis. 2004;10:1950.
- Dakshinamoorthy M., Venkatesh A., Arumugam K. A literature review on dental caries vaccine-a prevention strategy. Indian J Public Health. 2019;10:3041–3043.
- Forrester J.D., Spain D.A. Clostridium ramosum bacteremia: case report and literature review. Surg Infect. 2014;15:343–346.
- Gao J., Xu K., Liu H. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol. 2018;8:13.
- Verdu E.F., Hayes C.L., O’Mahony S.M. Elsevier; London: 2016. Importance of the microbiota in early life and influence on future health. In: The Gut-Brain Axis; pp. 159–184.
- Miquel S., Martin R., Rossi O. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2013;16:255–261.
- Kaakoush N.O. Insights into the role of Erysipelotrichaceae in the human host. Front Cell Infect Microbiol. 2015;5:84.
- Wang J., Li F., Wei H. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell–dependent inflammation. J Exp Med. 2014;211:2397–2410.
- Deriu E., Boxx G.M., He X. Influenza virus affects intestinal microbiota and secondary salmonella infection in the gut through type I interferons. PLoS Pathog. 2016;12
- Groves H.T., Cuthbertson L., James P. Respiratory disease following viral lung infection alters the murine gut microbiota. Front Immunol. 2018;9:182.
- Brundage J.F. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis. 2006;6:303–312.
- Habib S., Siddiqui A.H., Azam M. Actinomyces viscosus causing disseminated disease in a patient on methotrexate. Respir Med Case Rep. 2018;25:158–160.
- Vatanen T., Kostic A.D., d’Hennezel E. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell. 2016;165:842–853.
- Yoshida N., Emoto T., Yamashita T. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation. 2018;138:2486–2498.
- Qingxian C., Fengjuan C., Wang T. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43:1392–1398.
- Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8:e21.
- Hill M.A., Mantzoros C., Sowers J.R. Commentary: COVID-19 in patients with diabetes. Metabolism. 2020;107:154217.
- Mendes V., Galvao I., Vieira A.T. Mechanisms by which the gut microbiota influences cytokine production and modulates host inflammatory responses. J Interferon Cytokine Res. 2019;39:393–409.
- Tulstrup M.V.-L., Christensen E.G., Carvalho V. Antibiotic treatment affects intestinal permeability and gut microbial composition in Wistar rats dependent on antibiotic class. PLoS One. 2015;10
- Hagan T., Cortese M., Rouphael N. Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans. Cell. 2019;178:1313–1328.e13.
Source: PubMed